A detailed history of Bryn Mawr Trust CO transactions in Incyte Corp stock. As of the latest transaction made, Bryn Mawr Trust CO holds 146 shares of INCY stock, worth $10,206. This represents 0.0% of its overall portfolio holdings.

Number of Shares
146
Previous 12,532 98.83%
Holding current value
$10,206
Previous $759,000 98.81%
% of portfolio
0.0%
Previous 0.03%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 25, 2024

SELL
$57.33 - $68.61 $710,089 - $849,803
-12,386 Reduced 98.83%
146 $9,000
Q4 2021

Feb 10, 2022

SELL
$63.34 - $74.11 $31,670 - $37,055
-500 Reduced 3.84%
12,532 $920,000
Q1 2021

Apr 23, 2021

BUY
$76.02 - $100.5 $38,010 - $50,250
500 Added 3.99%
13,032 $1.06 Million
Q1 2020

May 08, 2020

BUY
$63.18 - $85.97 $791,771 - $1.08 Million
12,532 New
12,532 $918,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.6B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Bryn Mawr Trust CO Portfolio

Follow Bryn Mawr Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bryn Mawr Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Bryn Mawr Trust CO with notifications on news.